Antibiotic Selection for the Treatment of Infectious Complications of Implant-Based Breast Reconstruction
Authors:
- Katie E. WeichmanKWKatie E. Weichman
- Steve M. LevineSLSteve M. Levine
- Stelios C. WilsonSWStelios C. Wilson
- Mihye ChoiMCMihye Choi
- Nolan S. KarpNKNolan S. Karp
- 1 August 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 71 (2) , 140-143
Abstract
Infection requiring explantation remains the most devastating complication associated with implant-based breast reconstruction. There are many treatment algorithms to prevent reconstructive failure in face of infection using both oral and intravenous antibiotics. In the absence of patient-specific culture data, antibiotic selection is generally directed toward broad-spectrum coverage based on historical data. We hypothesize that reviewing our institution's microbiology data obtained from explanted implant-based breast reconstructions would provide a rational basis for antibiotic selection in the future. A retrospective review of 902 consecutive immediate implant-based breast reconstructions at a single institution from November 2007 to May 2011 was conducted. Implant reconstructions requiring explantation or drainage by interventional radiology were identified. Patient demographics, implant characteristics, presence of skin necrosis, microbiological data, and outcomes were reviewed. Forty-three (4.76%) implant reconstructions requiring explantation or drainage by interventional radiology met the inclusion criteria for this study. Five patients (11.6%) had round, smooth silicone implants, and 36 (88.4%) had textured tissue expanders. Twenty-six implants were explanted because of infection; 3, because of exposure from skin necrosis; and 11, because of the combination of flap necrosis and infection; and 1, secondarily because of cancer invasion into the skin. Reconstruction was salvaged in 21 breasts (51.2%): 12 (57.1%) by implant reconstruction, 5 (23.8%) by pedicled latissimus dorsi flaps, and 4 (19.1%) with a microvascular free flap. Thirty explants had microbiology data available. The most common organism isolated was Staphylococcus epidermidis (10), followed by methicillin-sensitive Staphylococcus aureus (5), Serratia marcescens (5), Pseudomonas aeruginosa (4), enterococcus (3), Escherichia coli (2), Enterobacter (2), group B streptococcus (1), and Morganella morganii (1). Forty percent of the organisms were resistant to cefazolin; however, 86% were sensitive to gentamicin, 80% were sensitive to Levaquin, and 63% were sensitive to ciprofloxacin. Infection associated with implant-based breast reconstructions continues to threaten explantation and reconstructive failure. Based on our microbiological data, initial cellulitis amenable to oral antibiotics should be treated with oral fluoroquinolones as a first-line treatment. If this regimen fails, intravenous imipenem or gentamicin and vancomycin should be initiated. Obviously, clinical judgment regarding specific patient risk factors and compliance should play a role in decision making, but these data provide an evidence-based rationale for first-line oral antibiotic selection.Keywords
This publication has 11 references indexed in Scilit:
- Extended Trimethoprim/Sulfamethoxazole Prophylaxis for Implant Reconstruction in the Previously Irradiated Chest WallPlastic and Reconstructive Surgery, 2012
- Management of the Infected or Exposed Breast Prosthesis: A Single Surgeonʼs 15-Year Experience with 69 PatientsPlastic and Reconstructive Surgery, 2010
- Implant-Based Breast Reconstruction Using Acellular Dermal Matrix and the Risk of Postoperative ComplicationsPlastic and Reconstructive Surgery, 2010
- Independent Risk Factors for Infection in Tissue Expander Breast ReconstructionPlastic and Reconstructive Surgery, 2009
- Skin and Soft-Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureusNew England Journal of Medicine, 2007
- Infections of Breast Implants in Aesthetic Breast Augmentations: A Single-Center Review of 3,002 PatientsAesthetic Plastic Surgery, 2007
- Infection in breast implantsThe Lancet Infectious Diseases, 2005
- Infectious Complications following Breast Reconstruction with Expanders and ImplantsPlastic and Reconstructive Surgery, 2003
- Complications Leading to Surgery after Breast ImplantationNew England Journal of Medicine, 1997
- AUGMENTATION MAMMAPLASTYPlastic and Reconstructive Surgery, 1970